Consolidated income statement
January 1 – December 31
|
millions of CHF |
|
|
2025 |
|
2024 |
|
|
Sales |
|
|
3’555.4 |
|
3’530.6 |
|
|
Cost of goods sold |
|
|
|
–2’332.1 |
|
–2’347.4 |
|
Gross profit |
|
|
|
1’223.2 |
|
1’183.2 |
|
Selling and distribution expenses |
|
|
|
–321.9 |
|
–335.2 |
|
General and administrative expenses |
|
|
|
–372.1 |
|
–382.5 |
|
Research and development expenses |
|
|
–77.6 |
|
–76.4 |
|
|
Net impairment loss on contract assets and trade accounts receivable |
|
|
|
–7.0 |
|
–0.6 |
|
Other operating income / (expenses), net |
|
|
–11.5 |
|
–6.0 |
|
|
Operating income (EBIT) |
|
|
|
433.1 |
|
382.5 |
|
Interest and securities income |
|
|
11.6 |
|
19.6 |
|
|
Interest expenses |
|
|
–29.5 |
|
–29.3 |
|
|
Other financial income / (expenses), net |
|
|
–16.7 |
|
–15.5 |
|
|
Share of profit / (loss) of associates and joint ventures |
|
|
–11.4 |
|
–3.8 |
|
|
Income before income tax expenses |
|
|
|
387.1 |
|
353.5 |
|
Income tax expenses |
|
|
–92.4 |
|
–88.2 |
|
|
Net income |
|
|
|
294.7 |
|
265.4 |
|
– thereof attributable to shareholders of Sulzer Ltd |
|
|
|
292.8 |
|
261.9 |
|
– thereof attributable to non-controlling interests |
|
|
|
1.9 |
|
3.5 |
|
|
|
|
|
|
|
|
|
Earnings per share (in CHF) |
|
|
|
|
|
|
|
Basic earnings per share |
|
|
8.68 |
|
7.73 |
|
|
Diluted earnings per share |
|
|
8.57 |
|
7.64 |